Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1

10.3390/vaccines9010056

Saved in:

Bibliographic Details
Main Authors:	Grabowska, Joanna, Stolk, Dorian A., Nijen Twilhaar, M.K., Ambrosini, Martino, Storm, Gert, van der Vliet, Hans J., de Gruijl, Tanja D., Kooyk, Y., den Haan, Joke M. M.
Other Authors:	SURGERY
Format:	Article
Published:	MDPI AG 2022
Subjects:	Alpha galactosylceramide Anti-tumor CD169 macrophage CDC1 Ganglioside GM3 Invariant natural killer T cell Liposomes Vaccination
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/233798
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-233798
record_format	dspace
spelling	sg-nus-scholar.10635-2337982024-11-12T20:11:33Z Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1 Grabowska, Joanna Stolk, Dorian A. Nijen Twilhaar, M.K. Ambrosini, Martino Storm, Gert van der Vliet, Hans J. de Gruijl, Tanja D. Kooyk, Y. den Haan, Joke M. M. SURGERY Alpha galactosylceramide Anti-tumor CD169 macrophage CDC1 Ganglioside GM3 Invariant natural killer T cell Liposomes Vaccination 10.3390/vaccines9010056 Vaccines 9 1 1-19 2022-10-26T09:16:52Z 2022-10-26T09:16:52Z 2021-01-16 Article Grabowska, Joanna, Stolk, Dorian A., Nijen Twilhaar, M.K., Ambrosini, Martino, Storm, Gert, van der Vliet, Hans J., de Gruijl, Tanja D., Kooyk, Y., den Haan, Joke M. M. (2021-01-16). Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1. Vaccines 9 (1) : 1-19. ScholarBank@NUS Repository. https://doi.org/10.3390/vaccines9010056 2076-393X https://scholarbank.nus.edu.sg/handle/10635/233798 Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/ MDPI AG Scopus OA2021
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Alpha galactosylceramide Anti-tumor CD169 macrophage CDC1 Ganglioside GM3 Invariant natural killer T cell Liposomes Vaccination
spellingShingle	Alpha galactosylceramide Anti-tumor CD169 macrophage CDC1 Ganglioside GM3 Invariant natural killer T cell Liposomes Vaccination Grabowska, Joanna Stolk, Dorian A. Nijen Twilhaar, M.K. Ambrosini, Martino Storm, Gert van der Vliet, Hans J. de Gruijl, Tanja D. Kooyk, Y. den Haan, Joke M. M. Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1
description	10.3390/vaccines9010056
author2	SURGERY
author_facet	SURGERY Grabowska, Joanna Stolk, Dorian A. Nijen Twilhaar, M.K. Ambrosini, Martino Storm, Gert van der Vliet, Hans J. de Gruijl, Tanja D. Kooyk, Y. den Haan, Joke M. M.
format	Article
author	Grabowska, Joanna Stolk, Dorian A. Nijen Twilhaar, M.K. Ambrosini, Martino Storm, Gert van der Vliet, Hans J. de Gruijl, Tanja D. Kooyk, Y. den Haan, Joke M. M.
author_sort	Grabowska, Joanna
title	Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1
title_short	Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1
title_full	Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1
title_fullStr	Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1
title_full_unstemmed	Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1
title_sort	liposomal nanovaccine containing α-galactosylceramide and ganglioside gm3 stimulates robust cd8+ t cell responses via cd169+ macrophages and cdc1
publisher	MDPI AG
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/233798
_version_	1821190914792488960

Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1

Similar Items